Monitor for further insider or institutional selling. Armistice Capital's exit below 5% removes a passive holder that previously held a meaningful position, potentially reducing support for the stock.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 16 $4.42entry
- T+1 · 15h ago +0.45%α +1.47% · $4.44
- T+5 · in 5d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Armistice Capital filed an amended Schedule 13G disclosing a 1.96% passive stake in Treace Medical Concepts as of September 30, 2026, down from a prior 5%+ position. The reduction below the 5% threshold signals a significant exit by a former top holder.
Key Financial Metrics
Key Facts
- Armistice Capital reported beneficial ownership of 6,364,000 shares of Treace Medical Concepts common stock as of September 30, 2026.
- The stake represents 1.96% of shares outstanding, down from a prior 5%+ position disclosed in May 2026.
- Armistice Capital is a passive filer under Rule 13d-1(b) and disclaims control intent.
- Steven Boyd, managing member of Armistice Capital, is also reported as a beneficial owner of the same shares.
Financial Impact
Armistice Capital reduced its stake from above 5% to 1.96%, representing a reduction of over 3 percentage points of ownership.
Risk Factors
- Loss of a significant institutional holder may signal reduced confidence in the company's outlook.
- The company's Q3 2026 revenue declined 4% YoY, and the stock has weak analyst consensus (5 Hold, 2 Sell, 2 Strong Sell).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001172661-26-005257 |
| Document: 0001172661-26-005257-index.html | 0001172661-26-005257 |
| Document: 0001172661-26-005257.txt | 0001172661-26-005257 |
Track record
11 reports on TMCI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
- Nov 16, 20261d ago SC 13G/A Bearish 4/10 Viewing Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
- Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
- Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
- Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
- Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
- May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
- Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
- Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers